Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Angelman & Rett Syndrome: Interaction and Communication

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03720028
Recruitment Status : Not yet recruiting
First Posted : October 25, 2018
Last Update Posted : October 25, 2018
Sponsor:
Collaborator:
KU Leuven
Information provided by (Responsible Party):
Universitaire Ziekenhuizen Leuven

Brief Summary:
We aim to describe the communicative and sensory profile of children with Angelman syndrome or Rett syndrome and their use of augmentative and alternative communication. In addition, parents are surveyed regarding parent-child interaction and access to communication support.

Condition or disease Intervention/treatment
Behavior, Child Parent-Child Relations Communication Behavioral: Observation Behavioral: Parental experiences

Layout table for study information
Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Parent-child Interaction and Communication in Families Who Have a Child With Rett Syndrome or Angelman Syndrome
Estimated Study Start Date : December 1, 2018
Estimated Primary Completion Date : October 1, 2020
Estimated Study Completion Date : October 1, 2020


Group/Cohort Intervention/treatment
Child w Angelman/Rett syndrome
Children with Angelman or Rett syndrome, up to 14 years of age
Behavioral: Observation
Describe communication and sensory profile using standardized tests and observations.

Parent
Parents of Children with Angelman or Rett syndrome
Behavioral: Parental experiences
Survey parents' experiences with parent-child interaction and augmentative and alternative communication.




Primary Outcome Measures :
  1. Communication profile [ Time Frame: 1 day One-time measurement ]
    Scores on language tests

  2. Parent interaction [ Time Frame: 1 day One-time measurement ]
    Scores on social tests



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Year to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Children with complex communication needs.
Criteria

Inclusion Criteria:

  • Angelman or Rett syndrome

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03720028


Locations
Layout table for location information
Belgium
Katholieke Universiteit Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
KU Leuven

Layout table for additonal information
Responsible Party: Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier: NCT03720028     History of Changes
Other Study ID Numbers: Snummer
First Posted: October 25, 2018    Key Record Dates
Last Update Posted: October 25, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Rett Syndrome
Mental Retardation, X-Linked
Intellectual Disability
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Genetic Diseases, X-Linked
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System